These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 15824372)

  • 1. A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS.
    Scelsa SN; MacGowan DJ; Mitsumoto H; Imperato T; LeValley AJ; Liu MH; DelBene M; Kim MY
    Neurology; 2005 Apr; 64(7):1298-300. PubMed ID: 15824372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Meininger V; Asselain B; Guillet P; Leigh PN; Ludolph A; Lacomblez L; Robberecht W;
    Neurology; 2006 Jan; 66(1):88-92. PubMed ID: 16401852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II/III randomized trial of TCH346 in patients with ALS.
    Miller R; Bradley W; Cudkowicz M; Hubble J; Meininger V; Mitsumoto H; Moore D; Pohlmann H; Sauer D; Silani V; Strong M; Swash M; Vernotica E;
    Neurology; 2007 Aug; 69(8):776-84. PubMed ID: 17709710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial.
    Levin BJ; Thompson G; Mitsumoto LH; Kaufmann P
    Neurology; 2006 Jun; 66(11):1786-7; author reply 1786-7. PubMed ID: 16769973
    [No Abstract]   [Full Text] [Related]  

  • 5. Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: a double- blind, randomized, multicentre, placebo-controlled trial.
    Meininger V; Drory VE; Leigh PN; Ludolph A; Robberecht W; Silani V
    Amyotroph Lateral Scler; 2009; 10(5-6):378-83. PubMed ID: 19922128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety of riluzole in amyotrophic lateral sclerosis.
    Lacomblez L; Bensimon G; Leigh PN; Debove C; Bejuit R; Truffinet P; Meininger V;
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Mar; 3(1):23-9. PubMed ID: 12061945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized sequential trial of creatine in amyotrophic lateral sclerosis.
    Groeneveld GJ; Veldink JH; van der Tweel I; Kalmijn S; Beijer C; de Visser M; Wokke JH; Franssen H; van den Berg LH
    Ann Neurol; 2003 Apr; 53(4):437-45. PubMed ID: 12666111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin in amyotrophic lateral sclerosis: a pilot, randomized, double-blind, placebo-controlled study of safety and tolerability.
    Lauria G; Campanella A; Filippini G; Martini A; Penza P; Maggi L; Antozzi C; Ciano C; Beretta P; Caldiroli D; Ghelma F; Ferrara G; Ghezzi P; Mantegazza R
    Amyotroph Lateral Scler; 2009; 10(5-6):410-5. PubMed ID: 19922132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor cortex stimulation for ALS: a double blind placebo-controlled study.
    Di Lazzaro V; Pilato F; Profice P; Ranieri F; Musumeci G; Florio L; Beghi E; Frisullo G; Capone F; Sabatelli M; Tonali PA; Dileone M
    Neurosci Lett; 2009 Oct; 464(1):18-21. PubMed ID: 19682544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
    Ferrante KL; Shefner J; Zhang H; Betensky R; O'Brien M; Yu H; Fantasia M; Taft J; Beal MF; Traynor B; Newhall K; Donofrio P; Caress J; Ashburn C; Freiberg B; O'Neill C; Paladenech C; Walker T; Pestronk A; Abrams B; Florence J; Renna R; Schierbecker J; Malkus B; Cudkowicz M
    Neurology; 2005 Dec; 65(11):1834-6. PubMed ID: 16344537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I; Camu W; Hillaire-Buys D
    Therapie; 2000; 55(2):303-12. PubMed ID: 10967703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials.
    Meininger V; Bensimon G; Bradley WR; Brooks B; Douillet P; Eisen AA; Lacomblez L; Leigh PN; Robberecht W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):107-17. PubMed ID: 15204012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline in amyotrophic lateral sclerosis: a pilot study.
    Pontieri FE; Ricci A; Pellicano C; Benincasa D; Buttarelli FR
    Neurol Sci; 2005 Oct; 26(4):285-7. PubMed ID: 16193258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trial of celecoxib in amyotrophic lateral sclerosis.
    Cudkowicz ME; Shefner JM; Schoenfeld DA; Zhang H; Andreasson KI; Rothstein JD; Drachman DB
    Ann Neurol; 2006 Jul; 60(1):22-31. PubMed ID: 16802291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolerance of riluzole in a phase IIIb clinical trial].
    Lacomblez L; Dib M; Doppler V; Faudet A; Robin V; Salachas F; Bensimon G; Meininger V
    Therapie; 2002; 57(1):65-71. PubMed ID: 12090150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial.
    Kim S; Kim JK; Son MJ; Kim D; Song B; Son I; Kang HW; Lee J; Kim S
    Trials; 2018 Apr; 19(1):225. PubMed ID: 29653550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    Aggarwal SP; Zinman L; Simpson E; McKinley J; Jackson KE; Pinto H; Kaufman P; Conwit RA; Schoenfeld D; Shefner J; Cudkowicz M;
    Lancet Neurol; 2010 May; 9(5):481-8. PubMed ID: 20363190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled study of reverse transcriptase in serum and CSF of HIV-negative patients with ALS.
    MacGowan DJ; Scelsa SN; Imperato TE; Liu KN; Baron P; Polsky B
    Neurology; 2007 May; 68(22):1944-6. PubMed ID: 17536052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS.
    Levy G; Kaufmann P; Buchsbaum R; Montes J; Barsdorf A; Arbing R; Battista V; Zhou X; Mitsumoto H; Levin B; Thompson JL
    Neurology; 2006 Mar; 66(5):660-3. PubMed ID: 16534103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.